Economist articles, blog examine research presented at AIDS 2012 conference

NewsGuard 100/100 Score

The Economist on Friday published two articles from Saturday's print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that "[f]ew areas of international affairs have seen more recent success than the fight against AIDS," and discusses advancements in HIV treatment research and availability (7/28). A second article provides a recap of several studies presented at the conference, notes "some people are starting to look beyond [current] antiretroviral (ARV) drugs," and writes, "Several clues suggest a cure may be possible" (7/28). In a related post, the Economist's "Babbage" blog reports on new tuberculosis (TB) research presented at the conference on Monday, which "found that a combination of one experimental drug, one drug approved for other infectious diseases and one existing TB drug had a comparable effect to standard TB treatment," suggesting "the combination may fight some TB strains resistant to other drugs -- and do so quite quickly" (7/26).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diet's role in fighting vitiligo highlighted in new research